BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 14, 2012
View Archived Issues
Scientists disclose new CD27-targeted candidate immunotherapeutics
Read More
GlaxoSmithKline presents highlights of 2011
Read More
Novel epithelial sodium channel blockers identified at Novartis
Read More
Metal chelators protect against proteins linked to neurodegenerative disorders
Read More
New antimicrobials specifically target NAD+-dependent DNA ligases
Read More
Antisense Therapeutics provides update on second-generation product
Read More
Neuropeptide W/neuropeptide B NPBW1 receptor antagonists described
Read More
New candidate cancer immunotherapies developed in France
Read More
Merck & Co. reports novel antibacterial immunotherapies
Read More
Novel products for hemophilia designed at Novo Nordisk
Read More
New bile acid GPBA receptor agonists developed at Roche
Read More
U.S. university patents new microRNA-based cancer therapies
Read More
Roche reports novel kinase inhibitors
Read More
U.S. scientists identify first inhibitors of menin/MLL fusion protein interaction
Read More
Alexza Pharmaceuticals receives first feedback on Adasuve MAA
Read More
Valeant Pharmaceuticals announces planned acquisition
Read More
BioDiem grants exclusive license for LAIV vaccine technology
Read More
Advanced Cell Technology treats third patient in phase I/II stem cell study
Read More
Celsion kicks off enrollment in ThermoDox trial
Read More
Phase III StemEx study is fully enrolled
Read More
Karo Bio discontinues development of eprotirome
Read More
Amylin Pharmaceuticals launches Bydureon in U.S.
Read More
CPP-115 receives European orphan drug status
Read More
FDA approves first preservative-free tafluprost ophthalmic solution
Read More
FDA grants priority review to Truvada sNDA
Read More
Cyclacel reports interim phase II data on sapacitabine in MDS
Read More
